Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | AXL | P30530 | 1/20 | 0.30 |
| ▸ | PRKCI | P41743 | 1/20 | 0.30 |
| ▸ | TNF | P01375 | 1/20 | 0.30 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22304289 | 0.80 | IDO1 (0.34) | ALDH1A1AXLPRKCIMETTGFBR1 | |
| SCHEMBL17278413 | 0.78 | TNF (0.36) | TNF | |
| SCHEMBL13577864 | 0.74 | SMN1; SMN2 (0.35) | ALDH1A1CYP3A4AXLMETTGFBR1 | |
| SCHEMBL2822958 | 0.73 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL2826725 | 0.69 | FABP3 (0.33) | — | |
| SCHEMBL15840579 | 0.68 | TNF (0.36) | TNF | |
| SCHEMBL12886366 | 0.68 | ALDH1A1 (0.40) | ALDH1A1CYP3A4PTGS1PTGS2TNF | |
| Ethane SCHEMBL6695707 | 0.66 | MAPT (0.37) | ALDH1A1CYP3A4PTGS2 | |
| SCHEMBL18509297 | 0.66 | PTGS1 (0.41) | PTGS1PTGS2 | |
| SCHEMBL12810046 | 0.66 | ALDH1A1 (0.55) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077602-A1 | Mixture composition for controlling ectoparasites | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077602-A1 | Mixture composition for controlling ectoparasites | SF3A3, PEX3, HCN3 | ALDH1A1 3278/4885CYP3A4 329/4885PTGS1 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.